Re: Redirecting Abiraterone Metabolism to Fine-Tune Prostate Cancer Anti-Androgen Therapy

Taneja Samir S.

首页> 外文期刊>The Journal of Urology >Re: Redirecting Abiraterone Metabolism to Fine-Tune Prostate Cancer Anti-Androgen Therapy

【24h】

Re: Redirecting Abiraterone Metabolism to Fine-Tune Prostate Cancer Anti-Androgen Therapy

机译：回复：将阿比特龙的代谢重定向至微调前列腺癌抗雄激素治疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of Urology》 |2016年第5期|共1页
作者
Taneja Samir S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy [J] . Li Zhenfei, Alyamani Mohammad, Li Jianneng, Nature . 2016,第7604期

机译：重定向阿比特龙代谢以微调前列腺癌抗雄激素治疗
2. Abiraterone acetate plus LHRH therapy versus abiraterone acetate while sparing LHRH therapy in patients with progressive, metastatic and chemotherapy-na?ve, castration-resistant prostate cancer (SPARE): study protocol for a randomized controlled trial [J] . Carsten-Henning Ohlmann, Michelle J?schke, Peter Jaehnig, Trials . 2017,第1期

机译：醋酸阿比特龙联合LHRH治疗与醋酸阿比特龙同时保留LHRH治疗进展性，转移性和初治性去势抵抗性前列腺癌（SPARE）的患者：一项随机对照试验的研究方案
3. Differential Androgen Deprivation Therapies with Anti-androgens Casodex/Bicalutamide or MDV3100/Enzalutamide versus Anti-androgen Receptor ASC-J9? Lead to Promotion versus Suppression of Prostate Cancer Metastasis [J] . Tzu-Hua Lin, Soo Ok Lee, Yuanjie Niu, The Journal of biological chemistry . 2013,第27期

机译：鉴别雄激素剥夺疗法与抗雄激素Casodex / Bicaletamide或MDV3100 /苯甲丁胺与抗雄激素受体ASC-J9？导致促进与前列腺癌转移的抑制
4. Vascular-Targeted Photodynamic of Prostate Cancer Phase with Tookad for Recurrent Prostate Cancer Following Radiation Therapy: Initial Clinical Studies [C] . Robert A. Weersink, Brian C. Wilson, Arjen Bogaards, Photonic Therapeutics and Diagnostics III; Progress in Biomedical Optics and Imaging; vol.8 no.1; Proceedings of SPIE-The International Society for Optical Engineering; vol.6424 . 2007

机译：Tookad用于前列腺癌放疗后复发性前列腺癌的血管靶向光动力学研究：初步临床研究
5. Emergence of metastatic hormone refractory disease in prostate cancer after anti-androgen therapy. [D] . Lee, Edmund Chun Yu. 2004

机译：抗雄激素治疗后前列腺癌中转移激素难治性疾病的出现。
6. Redirecting abiraterone metabolism to fine tune prostate cancer anti-androgen therapy [O] . Zhenfei Li, Mohammad Alyamani, Jianneng Li, -1

机译：重定向阿比特龙代谢以微调前列腺癌抗雄激素治疗
7. Correction: Differential androgen deprivation therapies with anti-androgens Casodex/bicalutamide or MDV3100/enzalutamide versus anti-androgen receptor ASC-J9® lead to promotion versus suppression of prostate cancer metastasis [O] . Tzu-Hua Lin, Soo Ok Lee, Yuanjie Niu, 2020

机译：校正：差分雄激素剥夺疗法抗雄激素Casodex / Bicalutamide或MDV3100 /苯甲丁胺与抗雄激素受体ASC-J9®导致促进与前列腺癌转移的抑制

Re: Redirecting Abiraterone Metabolism to Fine-Tune Prostate Cancer Anti-Androgen Therapy

著录项

相似文献

相关主题

期刊订阅